Bích-Mây Nguyễn :verified:<p>"States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them by surprise. </p><p>One solution some policymakers may try is restricting the number of people on Medicaid who can use the pricey diabetes drugs for weight-loss purposes."<br /> <a href="https://apnews.com/article/ozempic-wegovy-medicaid-weight-loss-glp1-dd34e5d76b660550dad73dc3069083ce" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://</span><span class="ellipsis">apnews.com/article/ozempic-weg</span><span class="invisible">ovy-medicaid-weight-loss-glp1-dd34e5d76b660550dad73dc3069083ce</span></a></p><p><a href="https://med-mastodon.com/tags/healthcare" class="mention hashtag" rel="tag">#<span>healthcare</span></a> <a href="https://med-mastodon.com/tags/PrescriptionDrugs" class="mention hashtag" rel="tag">#<span>PrescriptionDrugs</span></a> <a href="https://med-mastodon.com/tags/DrugPrices" class="mention hashtag" rel="tag">#<span>DrugPrices</span></a> <a href="https://med-mastodon.com/tags/CostsOfCare" class="mention hashtag" rel="tag">#<span>CostsOfCare</span></a> <a href="https://med-mastodon.com/tags/Medicaid" class="mention hashtag" rel="tag">#<span>Medicaid</span></a> <a href="https://med-mastodon.com/tags/obesity" class="mention hashtag" rel="tag">#<span>obesity</span></a></p>